ANALYSIS OF APOLIPOPROTEIN-B (APO-B) GENE IN ATHEROSCLEROSIS MICE GIVEN CURCUMINOID EXTRACT OF ZANTHORRIZA IN ORAL

Trini Susmiati, Rini Widayanti, Aris Purwantoro, Claude Mona Airin, Sarmin Sarmin

Abstract


The aim of this study was to investigate the apolipoprotein-B (apo-B) gene in atherosclerosis mice which were orally given curcuminoid extract of Curcuma xanthorriza. A total number of 30 white mice were split into 6 groups, the first group considered as control (without any treatment), second group as atherogenic feed control, the third group as extract control, while the fourth, fifth and sixth groups as atherogenic feed and curcuminoid Curcuma xanthorriza extract group treated with 5 mg/mouse, 10 mg/mouse and 15 mg/ mouse, respectively for three months. The blood samples were taken from all six groups for the deoxyribonucleic acid (DNA) analysis using total DNA isolation, DNA amplification with polymerase chain reaction (PCR), and DNA sequencing. The data analysis showed that 374 bp nucleotide sequence gen of apo-B from Rattus norvegicus in groups B, C, D, E, and F did not cause any changes in genes. The analysis showed the sequence of apo-B Rattus norvegicus gene in the treatment group was apparently identical with that of Rattus norvegicus group A as the control group without treatment. As conclusion, the administration of curcuminoid zanthorrizza to atherosclerosis mice did not change the gene structure of apo-B 100.

Keywords


atherogenic feed; curcuminoid zanthorriza extract apo-B gene; sequencing

Full Text:

PDF

References


Deodhar, S.D., R. Sethi, R.C.Srimal. 1980. Preliminary study on antirheumatic activity of curcumin (Diferuloyl methane). J. Ind. Med. Res. 71:632-634.

Hansson, G.K. 2009. Atherosclerosis-an immune disease: the Atnitschove lecture 2007. Atheroscler, 202(1):2:10.

Kaplan, M., M. Aviram. 2001. Retention of oxidation LDL by extracellular matrix proteoglycans leads to Its uptake by macrophages an alternative approach to Study lipoprotein cellular uptake. J. Arterioscler Thromb Vasc Biol. 21:386-393.

Kiso, Y.,Y. Suzuki, N.Watanabe, Y.Osima, H. Hikino.1983. Antihepatotoxic principles of curcuma Longa rhizomes. J, Med. Plant. Res. 49:185-187.

Law, S. W., K. J.Lackner, A. V. Hospattankar, J. M.Anchors, A. Y. Sakaguchi, S. L.Naylor, H. B. Brewer, Jr. 1985. Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc. Nat. Acad. Sci. 82: 8340-8344.

Libby, P. 2002. Inflamation in atherosclerosis. Nature 42:868-874.

Mc Gill HC Jr. 1968. Fatty Streak in the Coronary arteries and aorta. Lab. Invest 10: 560.

M.J.McQueen, S. Hawken, X.Wang. 2008. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study". Lancet 372 (9634): 224–33.

J.M. Munro, R.S. Cotrans. 1988. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58:249-261.

J.L. Quiles, M. Dolores, C.L.Ramires-Tortosa, C.M. Aquilera, M. Battina, A. Gill, M.C. Ramires-Tortosa. 2002. Curcuma longa extract suplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arteriolscler Thromb Vasc Biol. 22:1225-1231.

Rackley. C.E. 2007. Phathogenesis of Atherosclerosis. http://www.patiens.update.com/print.asp?print=true&file=chd/2109 [12 Juli 2009].

Rao, M.N.A. 1995. Antioxidant properties of curcumin. Proceeding of the International Symphosium on Curcumin Pharmacochemistry (ISCP), Yogyakarta Indonesia. Curcumin Pharmacochemistry. Yogyakarta.

Ross, R and J.A.Glomset. 1976. The pathogenesis of atherosclerosis. N. Eng.LJ. Med. 295: 369, 420.

Small, D.M. 1998. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry, Masachussets.

Sreejayan, N., M.N.A., Rao. 1997. Nitric oxid scavenging by curcuminoids. J. Phar. Pharmacols 49: 105 - 107.

Stary, H.C., A.B. Chandler, R.E.,Dnsmor, V.Fuster, S. Glagov, W. Insull, M.E. Rosenfeld, C.J.Schwart, W.D. Wagner and R.W. Wisller. 1990. A definition of advanced types of atherosclerotic Lesions and histological classification of atherosclerosis. Arteriolscler Thromb Vasc. Biol. 15:1512-1531.

Steinberg, D. 1993. Vitamin E for a healthy heart. New Eng. J. Med. 31:33- 58.

Tabas, I., K.J.Williams, J. Borén. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation (journal) 116 (16): 1832–1844. doi:10.1161/circulationaha.106 .

Tonnessen, H.H., H.D.Vries, J. Karlse, G.B. Henenggouwen. 1987. Studies of curcumin and curcuminoid in investigation of the photobiological activity of curcumin using bacterial indication system. J. Pharm. Sci. 76: 371-373.




DOI: https://doi.org/10.21157/j.ked.hewan.v13i2.10219

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 by author and J. Kedokt. Hewan

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indexed by:

           
  

p-ISSN: 1978-225X e-ISSN: 2502-5600 Copyright© 2007-2021